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ABSTRACT
Objective: In this study, we examined trends in severe
diabetes-related complications (acute myocardial
infarction, stroke, lower extremity amputation, and end-
stage renal disease) and prevalence of multiple
complications in a total population with diabetes in
Finland during an 18-year period.
Research design and methods: The total
population with diabetes aged 30 years or older in
1994–2011 was obtained from several Finnish health
registers. Only the first episode of each end point was
included in the analysis. We examined trends in the
prevalence of these end points using age-
standardization and changes in these end points were
analyzed using repeated-measures Poisson regression
models.
Results: The prevalence of single comorbidities
decreased during the study period, especially for acute
myocardial infarction and stroke. The age-adjusted and
diabetes duration-adjusted risk of having one of these
end points decreased throughout the study period
among persons with type 2 diabetes. Among women,
the risk ratio was 0.71 (0.63 to 0.79) in 2006–2011
compared to 1994–1999, and among men, the figure
was 0.72 (0.66 to 0.78). In type 1 diabetes, the risk of
multiple serious complications increased. We further
found increased mortality risk among persons with any
of these complications irrespective of diabetes type.
Conclusions: Our results concerning the development
of risk of complications suggest improvements in the
management of diabetes. More attention needs to be
paid to the prevention of complications among older
persons and those with longer history of diabetes to
prevent clustering of complications and to prevent the
diabetes epidemic in the population to reduce the
public health burden of diabetes.
INTRODUCTION
Population with diabetes is growing world-
wide due to an epidemic of type 2 diabetes1 2
and an increase in the incidence of type 1
diabetes.2 3 Further, improvements in the
diagnostic methods and earlier detection of
diabetes as well as improvements in diabetes
care increasing the life expectancy of
patients with diabetes have had an effect.
Diabetes requires continuous medical atten-
tion, including multifactorial risk reduction,
supporting patient self-management, preven-
tion of acute complications, and reduction of
the risk of long-term complications.4 The
main burden to population health and
healthcare comes from its microvascular and
macrovascular complications.5
While there is a growing literature con-
cerning multimorbidity in general including
Significance of this study
What is already known about this subject?
▪ There is a growing literature concerning multi-
morbidity in general including also diabetes and
concerning single complications of diabetes. The
studies show that the main burden to population
health and healthcare comes from its micro-
vascular and macrovascular complications.
What are the new findings?
▪ Our results show a marked decrease in risk of
one serious complication during the study
period among persons with type 2 diabetes,
mainly driven by decrease of acute myocardial
infarction and stroke among persons with
diabetes.
▪ However, according to our results, the risk of
multiple complications did not decrease among
persons with type 1 diabetes. This is likely to be
associated with aging of the diabetes population
and with advances in care increasing the likeli-
hood of survival with complications.
How might these results change the focus of
research or clinical practice?
▪ An important question for future studies is
whether there have been actual improvements in
the prevention of complications among persons
with already existing diabetes.
▪ More attention needs to be paid to the preven-
tion of complications among older persons and
those with longer history of diabetes to prevent
clustering of multiple complications and to pre-
vention of diabetes epidemic in the population to
reduce the public health burden of diabetes.
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also diabetes,6–8 and concerning single complications of
diabetes,9–14 studies investigating how several complica-
tions of diabetes cluster among individuals have mainly
examined complications as part of a broader framework
of multimorbidity and have mainly been based on
regional samples.15 16
The aim of this study was to examine trends in acute
myocardial infarction (AMI), stroke, lower extremity
amputation, and end-stage renal disease (ESRD) repre-
senting important complications of diabetes among
people aged 30 years or older in a total population with
diabetes in Finland between 1994 and 2011.
RESEARCH DESIGN AND METHODS
Population with diabetes
The population with diabetes was deﬁned as those
having any diabetes-related entries in any of the follow-
ing registers: the Hospital Discharge Register, the Cause
of Death Register, the Finnish Kidney Register, and drug
registers of the Social Insurance Institution between
1964 and 2011 and alive in 1 January 1994. For these
persons, information regarding the use of hospital ser-
vices and causes of death was individually linked using
the personal identiﬁcation code unique to each individ-
ual. Diabetes type was determined by register entries
concerning drug use: persons having entries on continu-
ous use of insulin but no signs of drug use increasing
insulin production of the pancreas were deﬁned as
having type 1 diabetes. Population at risk was deﬁned as
persons with diabetes aged 30 years or older in 1994–
2011. We formed annual cohorts of all individuals with
diabetes and alive in the beginning of the year and
those with incident diabetes during that year. Since we
examined complications of diabetes, the diabetes diag-
nosis needed to precede the complication entry. Persons
with gestational diabetes only were excluded from the
analyses.
Diabetes-related complications were deﬁned as right
for elevated health insurance reimbursement for drug
costs due to each of these complications granted by the
Social Insurance Institution, or an entry in the Hospital
Discharge Register, or Cause of Death Register or the
Finnish Kidney Register. We examined the following
complications: (1) stroke (ICD-9 and ICD-10 codes:
430*, 431*, 4330A, 4331A, 4339A, 4340A, 4341A, 4349A,
I60*, I61*, I63*), (2) AMI (ICD-9 and ICD-10 codes:
410*, I21*–I22*), (3) lower extremity amputation (LEA)
(Finnish Hospital League codes: 9571–9575, NOMESCO
codes: NFQ10, NFQ20, NGQ10, NGQ20, NHQ10,
NHQ20, NHQ30, or NHQ40), and (4) ESRD (entry in
the Finnish Kidney Register concerning the onset of
renal replacement therapy or cause of death codes 5855,
5856, N185, or N186). We examined the ﬁrst register
entry of each complication only as they are chronic con-
ditions. By only counting the ﬁrst register entry, we
wanted to ensure not counting the same complication
several times as each of the complications can result to
entries in different registers and several entries in the
hospital discharge register.
Statistical analyses
We examined trends in the prevalence of these compli-
cations by calculating age-standardized rates per 1000
using the 2011 diabetes population as a standard.
Multivariate analyses were based on repeated-measures
Poisson regression models controlling for age and dia-
betes duration. Separate models were calculated for
men and women. Trends in the clustering of complica-
tions were analyzed by comparing prevalence in 1994–
1999 to two later periods (2000–2005 and 2006–2011).
We further examined interactions between age and
period as well as duration of diabetes and period to
study whether the development was similar in different
subgroups. In additional analyses, we conducted Cox
regression models using counting process data to study
the effect of the four complications on survival until
death or censoring at the end of year 2011. Models were
ﬁtted for people with type 1 and type 2 diabetes separ-
ately and adjusted for gender, age, study period, and
duration of diabetes. Ethical approval for the study was
received from the Research Ethics Committee of the
National Institute for Health and Welfare.
RESULTS
There were altogether 145 738 persons with diabetes in
1994. The population with diabetes increased rapidly
during the study period (table 1) as did the proportion
of men in the population. More than 80% of the popu-
lation had type 2 diabetes in 1994 and the proportion
increased to 90% during the study period. The mean
duration of diabetes was longer toward the end of the
Table 1 Basic background characteristics of the
population with diabetes in 1994 and 2011 in Finland
Year 1994 2011
n 145 738 342 028
% %
Gender
Male 44 51
Female 56 49
Diabetes type
Type 1 17 10
Type 2 83 90
Age (years)
30–44 10 7
45–64 31 35
65–74 28 28
75–84 23 21
85+ 9 9
Diabetes duration (mean (SD))
Type 1 15.7 (9.0) 20.3 (14.4)
Type 2 6.3 (6.7) 7.3 (7.2)
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study period among type 1 and type 2 diabetes
population.
Figure 1 presents age-standardized trends in each
complication examined from 1994 to 2011 by diabetes
type. AMI and stroke were common among both patient
groups. Whereas AMI rates decreased during the study
period by a third among patients with type 2 diabetes
and by a fourth among patients with type 1 diabetes, the
decline in stroke was 21% among persons with type 2
diabetes and only 5% among those with type 1 diabetes.
LEA rates were much higher among persons with type 1
diabetes and remained on the same level throughout
the study period, but decreased by almost 50% among
those with type 2 diabetes. ESRD rates were much
higher among persons with type 1 diabetes and
remained similar throughout the study period among
both patient groups.
Since the prevalence of most complications studied
decreased in time, we examined the risk of
co-occurrence of one and of several complications with
diabetes adjusted for age and duration of diabetes, in
three time periods comparing years 2000–2005 and
2006–2011 to the beginning of the study period (1994–
1999) by diabetes type (table 2). The risk of having one
complication remained on approximately the same level
for persons with type 1 diabetes among men and
women throughout the study period. Among persons
with type 2 diabetes, the risk of having one complication
decreased steadily during the study period among both
genders. The risk of having two or more complications
increased by >25% from 1994–1999 to the beginning of
the 2000s among men and women with type 1 diabetes
and remained on the same level after that. Among
persons with type 2 diabetes, the risk of having two or
more complications diminished especially toward the
end of the study period.
We then examined whether the development in time
was similar among different age groups and by diabetes
duration. No signiﬁcant interactions were found among
either men or women with type 1 diabetes. However, the
risk of having one complication among persons with
type 2 diabetes and the risk of having two complications
among men were signiﬁcantly more pronounced among
older persons (all p values <0.05) and those with longer
Figure 1 The prevalence of complications (per 1000) among persons with diabetes in 1994–2011 in Finland by diabetes type.
AMI, acute myocardial infarction; ESRD, end-stage renal disease; LEA, lower extremity amputation.
Table 2 Change in age-standardized risk of multiple complications among persons with diabetes aged 30 years or older in
2000–2005 and 2006–2011 compared to period 1994–1999 (1.00), risk ratios, and their 95% CIs controlling for diabetes
duration
Type 1 Type 2
2000–2005 2006–2011 2000–2005 2006–2011
Women
1 complication 1.06 (1.01 to 1.12)* 1.00 (0.94 to 1.07) 0.89 (0.80 to 0.98)* 0.71 (0.63 to 0.79)***
≥2 complications 1.31 (1.14 to 1.50)*** 1.27 (1.09 to 1.47)** 0.96 (0.80 to 1.16) 0.72 (0.59 to 0.89)***
Men
1 complication 1.00 (0.95 to 1.05) 0.95 (0.90 to 1.00)* 0.89 (0.83 to 0.96)** 0.72 (0.66 to 0.78)***
≥2 complications 1.26 (1.10 to 1.43)*** 1.23 (1.08 to 1.40)** 1.09 (0.95 to 1.26) 0.84 (0.72 to 0.97)*
*p<0.05, **p<0.01, ***p<0.001.
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duration of diabetes (all p values <0.01) toward the end
of the study period.
We further analyzed excess mortality risk associated
with these complications. Signiﬁcantly increased mortal-
ity risk was found for each of the complications studied
among persons with type 1 and type 2 diabetes (table 3).
The mortality risk was highest and more than threefold
among persons with AMI or ESRD irrespective of dia-
betes type.
CONCLUSIONS
Overview of main results
This register-based study followed persons aged 30 years
and older with diabetes through an 18-year period and
examined the prevalence of four complications of dia-
betes. While AMI and stroke rates were on similar level
regardless of diabetes type, LEA and ESRD were much
more common among persons with type 1 diabetes.
Additionally, complication rates decreased less among
persons with type 1 diabetes during the study period.
The decrease in LEA rates among persons with type 2
diabetes is in line with earlier results suggesting decreas-
ing amputation rates among persons with diabetes in
Finland13 and elsewhere.11 Additionally, AMI and stroke
rates decreased in both patient groups in line with
earlier results.9 15 The risk of one serious complication
decreased during the study period among persons with
type 2 diabetes suggesting advances in secondary preven-
tion. However, part of the decrease especially among
persons with type 2 diabetes is likely to be due to
improvements in early diagnosis of the disease increas-
ing the number of persons with a milder stage of disease
in the population. The risk of multiple complications
did not decrease among persons with type 1 diabetes,
which is likely to be due to aging of the diabetes popula-
tion and advances in medical care increasing the likeli-
hood of survival with complications. Nevertheless, we
still found increased mortality risk among persons with
any of these complications. The mortality risk was
highest among persons with AMI and ESRD.
Methodological considerations
Our research data and indicators of complications were
based on several large administrative registers the validity
of which has, in general, been estimated to be good.17 18
As AMI, stroke, LEA, and ESRD are serious conditions
not treated in ambulatory care, most cases are likely to
be captured by the registers used in the current study. A
limitation of our study is that we could not examine ret-
inopathy, since comprehensive register data concerning
it do not exist in Finland. Our data on drug use were
based on reimbursement data of actual drug costs and
entitlements for elevated reimbursement of drug costs
based on standardized diagnostic criteria; false-positive
cases are therefore likely to be rare. Our results cover
complications among persons with diabetes diagnosed
in the healthcare system and treated with drugs, as those
with diabetes treated with diet only could not be identi-
ﬁed from the registers. Our data set has, however, been
shown to have relatively good coverage in comparison to
a local diabetes register from the Metropolitan area.19
Deﬁnition of diabetes type using register data only is a
challenge, and our deﬁnition was based on actual drug
purchases among persons with diabetes. We could not
examine the potential improvements made in ambula-
tory care in the prevention of complications suggested
by our results, since Finnish registers do not currently
cover comparable data concerning ambulatory service
use or clinical content of care for the whole country.
Conclusions
Our results suggest improvements in the management of
diabetes, but there are still patient groups among whom
more attention needs to be paid to multifactorial man-
agement of risk factors (glucose level, blood pressure,
lipid level, smoking) in order to avoid serious complica-
tions and clustering of multiple complications.20 More
attention needs to be paid to the prevention of complica-
tions among older persons and those with longer history
of diabetes to prevent clustering of multiple complica-
tions and to prevention of diabetes epidemic in the popu-
lation to reduce the public health burden of diabetes.
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Table 3 Mortality risk among persons with diabetes in
1994–2011 by diabetes type (HRs and their 95% CIs
controlling for gender, age, period, diabetes duration, and
all studied complications)
Type 1 Type 2
Complication HR 95% CI HR 95% CI
Stroke 2.23*** 2.13 to
2.34
2.25*** 2.22 to
2.28
AMI 3.88*** 3.72 to
4.04
3.35*** 3.31 to
3.40
LEA 2.17*** 2.05 to
2.29
2.11*** 2.06 to
2.17
ESRD 3.13*** 2.90 to
3.39
3.05*** 2.84 to
3.28
***p<0.001.
AMI, acute myocardial infarction; ESRD, end-stage renal disease;
LEA, lower extremity amputation.
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